<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardiovascular</journal-id><journal-title-group><journal-title xml:lang="ru">Кардиоваскулярная терапия и профилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Cardiovascular Therapy and Prevention</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1728-8800</issn><issn pub-type="epub">2619-0125</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1728-8800-2025-4409</article-id><article-id custom-type="edn" pub-id-type="custom">RHIMZT</article-id><article-id custom-type="elpub" pub-id-type="custom">cardiovascular-4409</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОЖИРЕНИЕ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>OBESITY</subject></subj-group></article-categories><title-group><article-title>Структурное ремоделирование миокарда у женщин и мужчин с ожирением первой степени: результаты сравнительного исследования</article-title><trans-title-group xml:lang="en"><trans-title>Structural myocardial remodeling in women and men with stage 1 obesity: results of a comparative study</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8993-7892</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рогожкина</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Rogozhkina</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Елизавета Александровна Рогожкина — м.н.с. лаборатории кардиовизуализации, вегетативной регуляции и сомнологии, ассистент кафедры кардиологии с курсом аритмологии и интервенционных методов диагностики и лечения.</p><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">lizarogozkina@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2812-959X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Иванова</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Ivanova</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Анна Александровна Иванова — м.н.с. отдела фундаментальных и прикладных аспектов ожирения, ассистент кафедры кардиологии с курсом аритмологии и интервенционных методов диагностики и лечения.</p><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">annaivanova12121@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5384-3795</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Джиоева</surname><given-names>О. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Dzhioeva</surname><given-names>O. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ольга Николаевна Джиоева — д.м.н., в.н.с. отдела фундаментальных и прикладных аспектов ожирения, директор Института профессионального образования, руководитель лаборатории кардиовизуализации, вегетативной регуляции и сомнологии.</p><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">dzhioevaon@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4453-8430</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Драпкина</surname><given-names>О. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Drapkina</surname><given-names>O. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Оксана Михайловна Драпкина — д.м.н., профессор, академик РАН, директор.</p><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">drapkina@bk.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ "Национальный медицинский исследовательский центр терапии и профилактической медицины" Минздрава России</institution></aff><aff xml:lang="en"><institution>National Medical Research Center for Therapy and Preventive Medicine</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ "Национальный медицинский исследовательский центр терапии и профилактической медицины" Минздрава России; ФГБОУ ВО "Российский университет медицины" Минздрава России</institution></aff><aff xml:lang="en"><institution>National Medical Research Center for Therapy and Preventive Medicine; Russian University of Medicine</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>11</day><month>08</month><year>2025</year></pub-date><volume>24</volume><issue>6</issue><fpage>4409</fpage><lpage>4409</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Рогожкина Е.А., Иванова А.А., Джиоева О.Н., Драпкина О.М., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Рогожкина Е.А., Иванова А.А., Джиоева О.Н., Драпкина О.М.</copyright-holder><copyright-holder xml:lang="en">Rogozhkina E.A., Ivanova A.A., Dzhioeva O.N., Drapkina O.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://cardiovascular.elpub.ru/jour/article/view/4409">https://cardiovascular.elpub.ru/jour/article/view/4409</self-uri><abstract><sec><title>Цель</title><p>Цель. Провести сравнительный анализ распределения жировой ткани (ЖТ), геометрии и функциональных показателей миокарда левых камер у женщин и мужчин с ожирением 1 ст. без диагностированных ранее сердечно-сосудистых заболеваний.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. В анализ включено 88 пациентов с ожирением 1 ст. в возрасте 25-50 лет, которые не имели в анамнезе сердечно-сосудистых и хронических неинфекционных заболеваний. В зависимости от пола исследуемые были разделены на 2 группы. В каждой группе оценивались структурно-функциональные параметры сердца, в т.ч. показатели продольной деформации, и распределение ЖТ. Исследования были выполнены на ультразвуковом аппарате Philips EPIQ CVx 2D одним специалистом.</p></sec><sec><title>Результаты</title><p>Результаты. У женщин определялись более высокие, чем у мужчин абсолютные (49,0 [41,0;57,5] vs 44,0 [37,0;54,0] мл, р=0,076) и индексированные показатели объема левого предсердия (ЛП) (18,3 [14,6;20,1] vs 14,7 [12,0;17,2] мл/м², p=0,015), а также бóльший индекс массы миокарда левого желудочка (42,2 [37,2;47,8] vs 33,0 [31,3;41,1] г/м²,7, р=0,001). У мужчин по сравнению с женщинами отмечались более высокие показатели резервуарной функции ЛП (LASr) (p=0,047), тогда как у женщин чаще наблюдалась дилатация ЛП (30 vs 10%, p=0,001). У мужчин вероятность увеличения размеров ЛП была в 5,2 раза ниже, чем у женщин (OR — odds ratio (отношение шансов) 0,192; 95% доверительный интервал: 0,068-0,541, р=0,002). У женщин была значительно выше вероятность снижения LASr (резервуарный стрейн ЛП) (OR 3,2, p=0,022), что может быть связано с особенностями распределения висцеральной ЖТ, в т.ч. и эпикардиально.</p></sec><sec><title>Заключение</title><p>Заключение. У женщин чаще выявляется дисфункция ЛП, что, вероятно, обусловлено большей выраженностью висцерального ожирения. Установленная связь с толщиной эпикардиальной ЖТ подтверждает важность ее оценки в стандартном эхокардиографическом протоколе. Полученные результаты позволяют утверждать, что снижение массы тела, особенно у женщин, должно быть приоритетным направлением профилактики сердечно-сосудистых осложнений.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To conduct a comparative analysis of the adipose tissue (AT) distribution and left myocardial geometry and functional parameters in women and men with class 1 obesity without previously diagnosed cardiovascular diseases.</p></sec><sec><title>Material and methods</title><p>Material and methods. The analysis included 88 patients with class 1 obesity aged 25-50 years who had no history of cardiovascular and non-communicable diseases. Depending on sex, the subjects were divided into 2 groups. In each group, the structural and functional cardiac parameters were assessed, including longitudinal strain indices and AT distribution. The studies were performed on a Philips EPIQ CVx 2D ultrasound system by one specialist.</p></sec><sec><title>Results</title><p>Results. Women had higher absolute (49,0 [41,0;57,5] vs, 44,0 [37,0;54,0] ml, p=0,076) and indexed left atrial (LA) volumes (18,3 [14,6;20,1] vs 14,7 [12,0;17,2] ml/m2, p=0,015) than men, as well as a higher left ventricular mass index (42,2 [37,2;47,8] vs 33,0 [31,3;41,1] g/m2,7, p=0,001). Men had higher left atrial strain during reservoir phase (LASr) (p=0,047) than women, whereas women were more likely to have LA dilation (30 vs 10%, p=0,001). In men, the pro­ba­bility of an increase in LA size was 5,2 times lower than in women (odds ratio (OR) 0,192; 95% confidence interval: 0,068-0,541, p=0,002). Wo­men had a significantly higher probability of a decrease in LASr (OR 3,2, p=0,022), which may be associated with specifics of visceral AT, including epicardial, distribution.</p></sec><sec><title>Conclusion</title><p>Conclusion. Women are more likely to have LA dysfunction, which is probably due to the greater severity of visceral obesity. The established relationship with epicardial AT thickness confirms the importance of its assessment in the standard echocardiographic protocol. The results obtained suggest that weight loss, especially in women, should be a priority for the prevention of cardiovascular events.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>ожирение</kwd><kwd>эпикардиальная жировая ткань</kwd><kwd>дисфункция левого предсердия</kwd><kwd>резервуарный стрейн</kwd><kwd>эхокардиография</kwd></kwd-group><kwd-group xml:lang="en"><kwd>obesity</kwd><kwd>epicardial adipose tissue</kwd><kwd>left atrial dysfunction</kwd><kwd>reservoir strain</kwd><kwd>echocardiography</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа выполнена в рамках госзадания ФГБУ "НМИЦ ТПМ" Минздрава России № И125011901994-4 (2025-2027гг) на тему "Разработка информационно-аналитической системы для прогнозирования и улучшения исходов путем оптимизации подходов к ведению пациентов с декомпенсированной сердечной недостаточностью с сохраненной фракцией выброса с использованием мультимаркерной стратегии и методов искусственного интеллекта"</funding-statement><funding-statement xml:lang="en">The work was carried out within the state assignment of the National Medical Research Center for Therapy and Preventive Medicine № I125011901994-4 (2025-2027) "Develop­ment of an information and analytical system for predicting and im­proving outcomes by optimizing approaches to managing patients with decompensated heart failure with preserved ejection fraction using a multimarker strategy and artificial intelligence methods"</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Алфёрова В. И., Мустафина С. В. Распространенность ожирения во взрослой популяции Российской Федерации (обзор литературы). Ожирение и метаболизм. 2022;19(1):96-105. doi:10.14341/omet12809.</mixed-citation><mixed-citation xml:lang="en">Alferova VI, Mustafina SV. The prevalence of obesity in the adult population of the Russian Federation (literature review). Obesity and metabolism. 2022;19(1):96-105. (In Russ.) doi:10.14341/omet12809.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128•9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627-42. doi:10.1016/S0140-6736(17)32129-3.</mixed-citation><mixed-citation xml:lang="en">NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128•9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627-42. doi:10.1016/S0140-6736(17)32129-3.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Здравоохранение в России. 2023: Статистический сборник. Федеральная служба государственной статистики. М.: Росстат. 2023. p. 179. (Рег. № З-46).</mixed-citation><mixed-citation xml:lang="en">Rosstat. Healthcare in Russia. 2023: Statistical Yearbook. Federal State Statistics Service. M.: Rosstat, 2023. p. 179. (Reg. No. Z-46). (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Koskinas KC, Van Craenenbroeck EM, Antoniades C, et al. Obesity and cardiovascular disease: an ESC clinical consensus statement. Eur Heart J. 2024;45(38):4063-98. doi:10.1093/eurheartj/ehae508.</mixed-citation><mixed-citation xml:lang="en">Koskinas KC, Van Craenenbroeck EM, Antoniades C, et al. Obesity and cardiovascular disease: an ESC clinical consensus statement. Eur Heart J. 2024;45(38):4063-98. doi:10.1093/eurheartj/ehae508.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Kasher Meron M, Eizenstein S, Cukierman-Yaffe T, et al. Missed diagnosis — a major barrier to patient access to obesity healthcare in the primary care setting. Intern J Obesity. 2024;48:1003-10. doi:10.1038/s41366-024-01514-6.</mixed-citation><mixed-citation xml:lang="en">Kasher Meron M, Eizenstein S, Cukierman-Yaffe T, et al. Missed diagnosis — a major barrier to patient access to obesity healthcare in the primary care setting. Intern J Obesity. 2024;48:1003-10. doi:10.1038/s41366-024-01514-6.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Баланова Ю. А., Драп­кина О. М., Куценко В. А. и др. Ожирение в российской популяции в период пандемии COVID-19 и факторы, с ним ассоциированные. Данные исследования ЭССЕ-РФ3. Кардиоваскулярная терапия и профилактика. 2023;22(8S):3793. doi:10.15829/1728-8800-2023-3793.</mixed-citation><mixed-citation xml:lang="en">Balanova YuA, Drapkina OM, Kutsenko VA, et al. Obesity in the Russian population during the COVID-19 pandemic and associated factors. Data from the ESSE-RF3 study. Cardiovascular Therapy and Prevention. 2023;22(8S):3793. (In Russ.) doi:10.15829/1728-8800-2023-3793.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Kaur G, Lau E. Sex differences in heart failure with preserved ejection fraction: From traditional risk factors to sex-specific risk factors. Womens Health (Lond). 2022;18:17455057221140209. doi:10.1177/17455057221140209.</mixed-citation><mixed-citation xml:lang="en">Kaur G, Lau E. Sex differences in heart failure with preserved ejection fraction: From traditional risk factors to sex-specific risk factors. Womens Health (Lond). 2022;18:17455057221140209. doi:10.1177/17455057221140209.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Schulz-Menger J, Abdel-Aty H, Rudolph A, et al. Gender-specific differences in left ventricular remodelling and fibrosis in hypertrophic cardiomyopathy: insights from cardiovascular magnetic reso­nance. Eur J Heart Fail. 2008;10(9):850-4. doi:10.1016/j.ejheart.2008.06.021.</mixed-citation><mixed-citation xml:lang="en">Schulz-Menger J, Abdel-Aty H, Rudolph A, et al. Gender-specific differences in left ventricular remodelling and fibrosis in hypertrophic cardiomyopathy: insights from cardiovascular magnetic reso­nance. Eur J Heart Fail. 2008;10(9):850-4. doi:10.1016/j.ejheart.2008.06.021.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Halland H, Lønnebakken MT, Pristaj N, et al. Sex differences in subclinical cardiac disease in overweight and obesity (the FATCOR study). Nutr Metab Cardiovasc Dis. 2018;28(10):1054-60. doi:10.1016/j.numecd.2018.06.014.</mixed-citation><mixed-citation xml:lang="en">Halland H, Lønnebakken MT, Pristaj N, et al. Sex differences in subclinical cardiac disease in overweight and obesity (the FATCOR study). Nutr Metab Cardiovasc Dis. 2018;28(10):1054-60. doi:10.1016/j.numecd.2018.06.014.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Lønnebakken M T, Izzo R, Mancusi C, et al. Left Ventricular Hypertrophy Regression During Antihypertensive Treatment in an Outpatient Clinic (the Campania Salute Network). J Am Heart Assoc. 2017;6(3):e004152. doi:10.1161/JAHA.116.004152.</mixed-citation><mixed-citation xml:lang="en">Lønnebakken M T, Izzo R, Mancusi C, et al. Left Ventricular Hypertrophy Regression During Antihypertensive Treatment in an Outpatient Clinic (the Campania Salute Network). J Am Heart Assoc. 2017;6(3):e004152. doi:10.1161/JAHA.116.004152.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Rogge BP, Gerdts E, Cramariuc D, et al. Impact of obesity and nonobesity on grading the severity of aortic valve stenosis. Am J Cardiology. 2014;113(9):1532-5. doi:10.1016/j.amjcard.2014.01.429.</mixed-citation><mixed-citation xml:lang="en">Rogge BP, Gerdts E, Cramariuc D, et al. Impact of obesity and nonobesity on grading the severity of aortic valve stenosis. Am J Cardiology. 2014;113(9):1532-5. doi:10.1016/j.amjcard.2014.01.429.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">de Simone G, Devereux RB, Chinali M, et al. Sex differences in obesity-related changes in left ventricular morphology: the Strong Heart Study. J Hypertens. 2011;29(7):1431-8. doi:10.1097/HJH.0b013e328347a093.</mixed-citation><mixed-citation xml:lang="en">de Simone G, Devereux RB, Chinali M, et al. Sex differences in obesity-related changes in left ventricular morphology: the Strong Heart Study. J Hypertens. 2011;29(7):1431-8. doi:10.1097/HJH.0b013e328347a093.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Thomas L, Marwick TH, Popescu BA, et al. Left Atrial Structure and Function, and Left Ventricular Diastolic Dysfunction: JACC State-of-the-Art Review. J Am Coll Cardiol. 2019;73(15):1961-77. doi:10.1016/j.jacc.2019.01.059.</mixed-citation><mixed-citation xml:lang="en">Thomas L, Marwick TH, Popescu BA, et al. Left Atrial Structure and Function, and Left Ventricular Diastolic Dysfunction: JACC State-of-the-Art Review. J Am Coll Cardiol. 2019;73(15):1961-77. doi:10.1016/j.jacc.2019.01.059.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Gerdts E, Wachtell K, Omvik P, et al. Left atrial size and risk of major cardiovascular events during antihypertensive treatment: losartan intervention for endpoint reduction in hypertension trial. Hypertension. 2007;49(2):311-6. doi:10.1161/01.HYP.0000254322.96189.85.</mixed-citation><mixed-citation xml:lang="en">Gerdts E, Wachtell K, Omvik P, et al. Left atrial size and risk of major cardiovascular events during antihypertensive treatment: losartan intervention for endpoint reduction in hypertension trial. Hypertension. 2007;49(2):311-6. doi:10.1161/01.HYP.0000254322.96189.85.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Gerdts E, Oikarinen L, Palmieri V, et al. Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study. Hypertension. 2002;39(3):739-43. doi:10.1161/hy0302.105683.</mixed-citation><mixed-citation xml:lang="en">Gerdts E, Oikarinen L, Palmieri V, et al. Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study. Hypertension. 2002;39(3):739-43. doi:10.1161/hy0302.105683.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Kizer JR, Bella JN, Palmieri V, et al. Left atrial diameter as an independent predictor of first clinical cardiovascular events in middleaged and elderly adults: the Strong Heart Study (SHS). Am Heart J. 2006;151(2):412-8. doi:10.1016/j.ahj.2005.04.031.</mixed-citation><mixed-citation xml:lang="en">Kizer JR, Bella JN, Palmieri V, et al. Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: the Strong Heart Study (SHS). Am Heart J. 2006;151(2):412-8. doi:10.1016/j.ahj.2005.04.031.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Stritzke J, Markus MR, Duderstadt S, et al. The aging process of the heart: obesity is the main risk factor for left atrial enlargement during aging the MONICA/KORA (monitoring of trends and determinations in cardiovascular disease/cooperative research in the region of Augsburg) study. J Am Coll Cardiol. 2009;54(21):1982-9. doi:10.1016/j.jacc.2009.07.034.</mixed-citation><mixed-citation xml:lang="en">Stritzke J, Markus MR, Duderstadt S, et al. The aging process of the heart: obesity is the main risk factor for left atrial enlargement during aging the MONICA/KORA (monitoring of trends and determinations in cardiovascular disease/cooperative research in the region of Augsburg) study. J Am Coll Cardiol. 2009;54(21):1982-9. doi:10.1016/j.jacc.2009.07.034.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Hu FB. Overweight and obesity in women: health risks and con­sequences. J Women’s Health (Larchmt). 2003;12(2):163-72. doi:10.1089/154099903321576565.</mixed-citation><mixed-citation xml:lang="en">Hu FB. Overweight and obesity in women: health risks and con­sequences. J Women’s Health (Larchmt). 2003;12(2):163-72. doi:10.1089/154099903321576565.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Джиоева О. Н., Тимофеев Ю. С., Метельская В. А. и др. Роль эпикардиальной жировой ткани в патогенезе хронического воспаления при сердечной недостаточности с сохраненной фракцией выброса. Кардиоваскулярная терапия и профилактика. 2024;23(3):3928. doi:10.15829/1728-8800-2024-3928.</mixed-citation><mixed-citation xml:lang="en">Dzhioeva ON, Timofeev YuS, Metelskaya VA, et al. Role of epicardial adipose tissue in the pathogenesis of chronic inflammation in heart failure with preserved ejection fraction. Cardiovascular Therapy and Prevention. 2024;23(3):3928. (In Russ.) doi:10.15829/1728-8800-2024-3928.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Khan MS, Memon MM, Murad MH, et al. Left atrial function in heart failure with preserved ejection fraction: a systematic review and meta-analysis. Eur J Heart Fail. 2020;22(3):472-85. doi:10.1002/ejhf.1643.</mixed-citation><mixed-citation xml:lang="en">Khan MS, Memon MM, Murad MH, et al. Left atrial function in heart failure with preserved ejection fraction: a systematic review and meta-analysis. Eur J Heart Fail. 2020;22(3):472-85. doi:10.1002/ejhf.1643.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Широков Н. Е., Ярославская Е. И., Криночкин Д. В. и др. Принципы диагностики сердечной недостаточности с сохраненной фракцией выброса. Российский кардиологический журнал. 2023;28(3S):5448. doi:10.15829/1560-4071-2023-5448.</mixed-citation><mixed-citation xml:lang="en">Shirokov NE, Yaroslavskaya EI, Krinochkin DV, et al. Principles for diagnosing heart failure with preserved ejection fraction. Russian Journal of Cardiology. 2023;28(3S):5448. doi:10.15829/1560-4071-2023-5448.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Duca F, Zotter-Tufaro C, Kammerlander AA, et al. Gender-related differences in heart failure with preserved ejection fraction. Scientific reports. 2018;8(1):1080. doi:10.1038/s41598-018-19507-7.</mixed-citation><mixed-citation xml:lang="en">Duca F, Zotter-Tufaro C, Kammerlander AA, et al. Genderrelated differences in heart failure with preserved ejection fraction. Scientific reports. 2018;8(1):1080. doi:10.1038/s41598-018-19507-7.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Berg-Hansen CE, Sindre RB, Grymyr LMD, et al. Sex differences in left atrial volumes, mechanics, and stiffness in primary mitral regurgitationa combined 2D and 3D echocardiographic study. Eur Heart J Cardiovasc Imaging. 2024;25(8):1118-26. doi:10.1093/ehjci/jeae072.</mixed-citation><mixed-citation xml:lang="en">Berg-Hansen CE, Sindre RB, Grymyr LMD, et al. Sex differences in left atrial volumes, mechanics, and stiffness in primary mitral regurgitationa combined 2D and 3D echocardiographic study. Eur Heart J Cardiovasc Imaging. 2024;25(8):1118-26. doi:10.1093/ehjci/jeae072.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Логачева И. В., Рязанова Т. А., Макарова В. Р. и др. Ремоделирование сердца у больных с избыточной массой тела и ожирением при коморбидной кардиальной патологии. Российский кардиологический журнал. 2017;(4):40-6. doi:10.15829/1560-4071-2017-4-40-46.</mixed-citation><mixed-citation xml:lang="en">Logacheva IV, Ryazanova ТА, Makarova VR, et al. Heart remodeling in overweight and obesity with cardiac comorbidities. Russian Journal of Cardiology. 2017;(4):40-6. (In Russ.) doi:10.15829/1560-4071-2017-4-40-46.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Гриценко О. В., Чумакова Г. А., Шевляков И. В. и др. Механизмы развития сердечной недостаточности при ожирении. Российский кардиологический журнал. 2018;(5):81-6. doi:10.15829/1560-4071-2018-5-81-86.</mixed-citation><mixed-citation xml:lang="en">Gritsenko ОV, Chumakova GА, Shevlyakov IV, et al. The mechanisms of heart failure development in obesity. Russian Journal of Cardiology. 2018;(5):81-6. (In Russ.) doi:10.15829/1560-4071-2018-5-81-86.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Mancia G, Kreutz R, Brunström M, et al. 2023 ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Socie­ty of Hypertension: Endorsed by the International Society of Hyper­tension (ISH) and the European Renal Association (ERA). J Hypertension. 2023;41(12):1874-2071. doi:10.1097/HJH.0000000000003480.</mixed-citation><mixed-citation xml:lang="en">Mancia G, Kreutz R, Brunström M, et al. 2023 ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Socie­ty of Hypertension: Endorsed by the International Society of Hyper­tension (ISH) and the European Renal Association (ERA). J Hypertension. 2023;41(12):1874-2071. doi:10.1097/HJH.0000000000003480.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Wang W, Chen Y, Qiu XP, et al. The association of perirenal adipose tissue accumulation with left ventricular hypertrophy and the mediating role of insulin resistance: a cross-sectional study involving 1112 individuals with type 2 diabetes mellitus. Front Endocrinol. 2025;15:1465577. doi:10.3389/fendo.2024.1465577.</mixed-citation><mixed-citation xml:lang="en">Wang W, Chen Y, Qiu XP, et al. The association of perirenal adipose tissue accumulation with left ventricular hypertrophy and the mediating role of insulin resistance: a cross-sectional study involving 1112 individuals with type 2 diabetes mellitus. Front Endocrinol. 2025;15:1465577. doi:10.3389/fendo.2024.1465577.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Patel DA, Lavie CJ, Artham SM, et al. Effects of left ventricular geo­metry and obesity on mortality in women with normal ejection fraction. Am J Cardiol. 2014;113(5):877-80. doi:10.1016/j.amjcard.2013.11.041.</mixed-citation><mixed-citation xml:lang="en">Patel DA, Lavie CJ, Artham SM, et al. Effects of left ventricular geo­metry and obesity on mortality in women with normal ejection fraction. Am J Cardiol. 2014;113(5):877-80. doi:10.1016/j.amjcard.2013.11.041.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">de Simone G, Izzo R, De Luca N, et al. Left ventricular geometry in obesity: Is it what we expect? Nutr Metab Cardiovasc Dis. 2013; 23(10):905-12. doi:10.1016/j.numecd.2013.06.012.</mixed-citation><mixed-citation xml:lang="en">de Simone G, Izzo R, De Luca N, et al. Left ventricular geometry in obesity: Is it what we expect? Nutr Metab Cardiovasc Dis. 2013; 23(10):905-12. doi:10.1016/j.numecd.2013.06.012.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
